1 – 47 of 47
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hairy cell leukemia variant and WHO classification correspondence Re : 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis
(
- Contribution to journal › Letter
-
Mark
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression
(
- Contribution to journal › Letter
-
Mark
A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia
2024) In Leukemia(
- Contribution to journal › Article
-
Mark
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults—a BMTSS report
(
- Contribution to journal › Article
-
Mark
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
(
- Contribution to journal › Article
- 2023
-
Mark
Perspectives of current understanding and therapeutics of Diamond-Blackan anemia
2023) In Leukemia(
- Contribution to journal › Scientific review
- 2022
-
Mark
Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma : a study of younger patients from the MCL2 and MCL3 clinical trials
(
- Contribution to journal › Article
-
Mark
Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia
2022) In Leukemia(
- Contribution to journal › Letter
-
Mark
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2021
-
Mark
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma : the DSHNHL2006-1B/ACT-2 trial
(
- Contribution to journal › Article
-
Mark
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting
(
- Contribution to journal › Article
-
Mark
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib
(
- Contribution to journal › Article
-
Mark
Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencing
(
- Contribution to journal › Letter
-
Mark
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Genetic predisposition for multiple myeloma
(
- Contribution to journal › Scientific review
-
Mark
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia : a Nordic Society of Pediatric Hematology and Oncology study
(
- Contribution to journal › Article
-
Mark
S100A6 is a critical regulator of hematopoietic stem cells.
2020) In Leukemia(
- Contribution to journal › Article
-
Mark
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism
(
- Contribution to journal › Article
-
Mark
FLT3
N676K
drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
(
- Contribution to journal › Letter
-
Mark
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
(
- Contribution to journal › Letter
- 2018
-
Mark
Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia : a report from the Blood or Marrow Transplant Survivor Study-2
(
- Contribution to journal › Article
-
Mark
Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
(
- Contribution to journal › Article
-
Mark
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies
(
- Contribution to journal › Article
-
Mark
Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden
(
- Contribution to journal › Letter
-
Mark
Early death rates remain high in high-risk APL : Update from the Swedish Acute Leukemia Registry 1997-2013
(
- Contribution to journal › Letter
-
Mark
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1
(
- Contribution to journal › Article
-
Mark
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia : A population-based study in Sweden
(
- Contribution to journal › Letter
-
Mark
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts : Comparison with myeloma
(
- Contribution to journal › Article
- 2016
-
Mark
The concept of treatment-free remission in chronic myeloid leukemia
(
- Contribution to journal › Scientific review
-
Mark
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
(
- Contribution to journal › Article
-
Mark
Harmonemia : A universal strategy for flow cytometry immunophenotyping - A European LeukemiaNet WP10 study
(
- Contribution to journal › Letter
- 2014
-
Mark
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes - Proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
(
- Contribution to journal › Scientific review
-
Mark
Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse
(
- Contribution to journal › Letter
- 2002
-
Mark
Development of gene therapy for hematopoietic stem cells using lentiviral vectors
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Timing, targeting and sorting of azurophil granule proteins in human myeloid cells
(
- Contribution to journal › Article
- 1997
-
Mark
LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1
(
- Contribution to journal › Article
-
Mark
Chromosomal translocations and leukaemia : a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis
(
- Contribution to journal › Article
- 1996
-
Mark
Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia
(
- Contribution to journal › Article